Terms: = Pancreatic cancer AND PBX1, P40424, 5087 AND Treatment
3 results:
1. Is there an oligometastatic state in pancreatic cancer? Practical clinical considerations raise the question.
Scorsetti M; Comito T; Franceschini D; Franzese C; Prete MG; D'Alessio A; Bozzarelli S; Rimassa L; Santoro A
Br J Radiol; 2020 Feb; 93(1106):20190627. PubMed ID: 31825664
[TBL] [Abstract] [Full Text] [Related]
2. The pioneer factor pbx1 is a novel driver of metastatic progression in ERα-positive breast cancer.
Magnani L; Patten DK; Nguyen VT; Hong SP; Steel JH; Patel N; Lombardo Y; Faronato M; Gomes AR; Woodley L; Page K; Guttery D; Primrose L; Fernandez Garcia D; Shaw J; Viola P; Green A; Nolan C; Ellis IO; Rakha EA; Shousha S; Lam EW; Győrffy B; Lupien M; Coombes RC
Oncotarget; 2015 Sep; 6(26):21878-91. PubMed ID: 26215677
[TBL] [Abstract] [Full Text] [Related]
3. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer.
Marin-Muller C; Li D; Bharadwaj U; Li M; Chen C; Hodges SE; Fisher WE; Mo Q; Hung MC; Yao Q
Clin Cancer Res; 2013 Nov; 19(21):5901-13. PubMed ID: 23989979
[TBL] [Abstract] [Full Text] [Related]
